Revenue Estimates Analysis of Franklin Resources, Inc.(NYSE:BEN): Surface Oncology, Inc.(NASDAQ:SURF)

0
6

Franklin Resources, Inc. (BEN) will report its next earnings on Jul 30 BMO. The company reported the earnings of $0.48/Share in the last quarter where the estimated EPS by analysts was $0.62/share. The difference between the expected and actual EPS was $-0.14/share, which represents an Earnings surprise of -22.6%.

Many analysts are providing their Estimated Earnings analysis for Franklin Resources, Inc. and for the current quarter 13 analysts have projected that the stock could give an Average Earnings estimate of $0.66/share. These analysts have also projected a Low Estimate of $0.59/share and a High Estimate of $0.71/share.

In case of Revenue Estimates, 9 analysts have provided their consensus Average Revenue Estimates for Franklin Resources, Inc. as 1.48 Billion. According to these analysts, the Low Revenue Estimate for Franklin Resources, Inc. is 1.47 Billion and the High Revenue Estimate is 1.5 Billion. The company had Year Ago Sales of 1.53 Billion.

These analysts also forecasted Growth Estimates for the Current Quarter for BEN to be -15.2%. They are projecting Next Quarter growth of 27.78%. For the next 5 years, Franklin Resources, Inc. is expecting Growth of 13.92% per annum, whereas in the past 5 years the growth was -23.2% per annum.

Some buy side analysts are also providing their Analysis on Franklin Resources, Inc., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 1 said it’s a HOLD, and 1 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Franklin Resources, Inc. might touch $34 high while the Average Price Target and Low price Target is $30.62 and $24 respectively.

Franklin Resources, Inc. closed its last trading session at $26.92 with the gain of 3.19%. The Market Capitalization of the company stands at 14.05 Billion. The Company has 52-week high of $35.82 and 52-week low of $25.57. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 3.12% where SMA50 and SMA200 are -10.98% and -13.7% respectively. The Company Touched its 52-Week High on 04/15/19 and 52-Week Low on 08/28/19.

The Relative Volume of the company is 1.07 and Average Volume (3 months) is 3.03 million. The company’s P/E (price to earnings) ratio is 10.98 and Forward P/E ratio of 10.3.

The company shows its Return on Assets (ROA) value of 9.7%. The Return on Equity (ROE) value stands at 14%. While it’s Return on Investment (ROI) value is 15.2%.

While looking at the Stock’s Performance, Franklin Resources, Inc. currently shows a Weekly Performance of 5.71%, where Monthly Performance is -9.13%, Quarterly performance is -16.83%, 6 Months performance is -13.57% and yearly performance percentage is -8.2%. Year to Date performance value (YTD perf) value is -6.34%. The Stock currently has a Weekly Volatility of 1.86% and Monthly Volatility of 2.31%.

Surface Oncology, Inc. (SURF) will report its next earnings on Aug 13. The company reported the earnings of $-0.64/Share in the last quarter where the estimated EPS by analysts was $-0.61/share. The difference between the expected and actual EPS was $-0.03/share, which represents an Earnings surprise of -4.9%.

Many analysts are providing their Estimated Earnings analysis for Surface Oncology, Inc. and for the current quarter 3 analysts have projected that the stock could give an Average Earnings estimate of $-0.58/share. These analysts have also projected a Low Estimate of $-0.59/share and a High Estimate of $-0.57/share.

In case of Revenue Estimates, 3 analysts have provided their consensus Average Revenue Estimates for Surface Oncology, Inc. as 2.03 Million. According to these analysts, the Low Revenue Estimate for Surface Oncology, Inc. is 600 Million and the High Revenue Estimate is 3 Million. The company had Year Ago Sales of 1.73 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for SURF to be 6.5%. They are projecting Next Quarter growth of -264.71%. For the next 5 years, Surface Oncology, Inc. is expecting Growth of -15.18% per annum, whereas in the past 5 years the growth was -478.79% per annum.

Some buy side analysts are also providing their Analysis on Surface Oncology, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Surface Oncology, Inc. might touch $14 high while the Average Price Target and Low price Target is $10.5 and $6 respectively.

Surface Oncology, Inc. closed its last trading session at $1.95 with the loss of -5.13%. The Market Capitalization of the company stands at 51.8 Million. The Company has 52-week high of $12.65 and 52-week low of $1.86. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -9.45% where SMA50 and SMA200 are -19.66% and -56.75% respectively. The Company Touched its 52-Week High on 09/20/18 and 52-Week Low on 09/09/19.

The Relative Volume of the company is 0.18 and Average Volume (3 months) is 53.9 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -25.6%. The Return on Equity (ROE) value stands at -44.6%. While it’s Return on Investment (ROI) value is -6.4%.

While looking at the Stock’s Performance, Surface Oncology, Inc. currently shows a Weekly Performance of -10.19%, where Monthly Performance is -12.74%, Quarterly performance is -53.16%, 6 Months performance is -58.8% and yearly performance percentage is -81.06%. Year to Date performance value (YTD perf) value is -56.37%. The Stock currently has a Weekly Volatility of 5.53% and Monthly Volatility of 8.33%.

SHARE